Encompass Health Stock News

BIRMINGHAM, Ala., Feb. 25, 2022 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC) today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.28 per share, payable on April 18, 2022, to holders of record on April 1, 2022. About…

BIRMINGHAM, Ala., Feb. 24, 2022 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will participate in the Barclays Global Healthcare Conference, which is being held in Miami, Flor

Seth Klarman''s Baupost fund took new positions in Fiserv, NortonLifeLock and Encompass Health as it exited eBay and Shaw Communications. See more info on Baupost holdings here.

Encompass Health (EHC) stated Friday that it has issued notice for final redemption of its remaining $100M principal amount of 5.125% senior notes due 2023. Redemption date is set to…

Encompass Health Corporation found using ticker (EHC) have now 12 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 104 and 69 with the average target price sitting at 85.17. Given that the stocks previous close was at 60.25 this is indicating there is a potential upside of 41.4%. There is a 50 day moving average of 62.9 and the 200 day moving average is 73.83. The company has a market cap of $5,920m. You can visit the company''s website by visiting: https://www.encompasshealth.com [stock_market_widget type="chart" symbol="EHC" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] The potential market cap would be $8,368m based on the market concensus. Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors

BIRMINGHAM, Ala., Feb. 4, 2022 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will participate in the SVB Leerink 11th Annual Virtual Global Healthcare Conference taking place F

Encompass Health's (EHC) Q4 results reflect escalating costs, partly offset by higher revenues, courtesy of its Inpatient Rehabilitation segment.

Encompass Health Corporation (EHC) CEO Mark Tarr on Q4 2021 Results - Earnings Call Transcript

Encompass Health Corporation EHC posted Q4 sales of $1.32 billion, +8.6% Y/Y, in line with the consensus of $1.32. Thousands of new traders are learning the ins and outs on how to find profitable tr

Encompass Health (EHC) delivered earnings and revenue surprises of -8.49% and 1.09%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

The following two stocks have underperformed the broader market recently. They are also in financial distress, as represented by low Altman Z-Scores, meaning that they could go bankrupt within the nex

Encompass Health (EHC) expects the Enhabit Home Health & Hospice spinoff to be completed in first-half 2022.

Encompass Health Corp (NYSE: EHC ) plans to spin off its home health and hospice (HH&H) business into an independent, publicly-traded company and rebrand as Enhabit Home Health & Hospice . Encompass Health offers facility-based and home-based patient care through its network of inpatient Full story available on Benzinga.com

Encompass Health Corp (NYSE: EHC) plans to spin off its home health and hospice (HH&H) business into an independent, publicly-traded company and rebrand as Enhabit Home Health & Hospice.  Encompa